141 related articles for article (PubMed ID: 36940177)
1. Measurement of Ovarian Tumor Immune Profiles by Multiplex Immunohistochemistry: Implications for Epidemiologic Studies.
Hathaway CA; Conejo-Garcia JR; Fridley BL; Rosner B; Saeed-Vafa D; Moran Segura C; Nguyen JV; Hecht JL; Sasamoto N; Terry KL; Tworoger SS; Townsend MK
Cancer Epidemiol Biomarkers Prev; 2023 Jun; 32(6):848-853. PubMed ID: 36940177
[TBL] [Abstract][Full Text] [Related]
2. Tumor immune cell clustering and its association with survival in African American women with ovarian cancer.
Wilson C; Soupir AC; Thapa R; Creed J; Nguyen J; Segura CM; Gerke T; Schildkraut JM; Peres LC; Fridley BL
PLoS Comput Biol; 2022 Mar; 18(3):e1009900. PubMed ID: 35235563
[TBL] [Abstract][Full Text] [Related]
3. The relationship of lifetime history of depression on the ovarian tumor immune microenvironment.
Hathaway CA; Townsend MK; Conejo-Garcia JR; Fridley BL; Moran Segura C; Nguyen JV; Armaiz-Pena GN; Sasamoto N; Saeed-Vafa D; Terry KL; Kubzansky LD; Tworoger SS
Brain Behav Immun; 2023 Nov; 114():52-60. PubMed ID: 37557966
[TBL] [Abstract][Full Text] [Related]
4. Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissue.
Parra ER; Ferrufino-Schmidt MC; Tamegnon A; Zhang J; Solis L; Jiang M; Ibarguen H; Haymaker C; Lee JJ; Bernatchez C; Wistuba II
Sci Rep; 2021 Apr; 11(1):8511. PubMed ID: 33875760
[TBL] [Abstract][Full Text] [Related]
5. Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types.
Zlobec I; Koelzer VH; Dawson H; Perren A; Lugli A
J Transl Med; 2013 Apr; 11():104. PubMed ID: 23627766
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer.
Bartl T; Alberts A; Papadopoulos SC; Wolf A; Muellauer L; Hofstetter G; Grimm C; Cacsire Castillo-Tong D
Int J Gynecol Cancer; 2023 Sep; 33(9):1419-1426. PubMed ID: 37094966
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution.
Dora D; Rivard C; Yu H; Bunn P; Suda K; Ren S; Lueke Pickard S; Laszlo V; Harko T; Megyesfalvi Z; Moldvay J; Hirsch FR; Dome B; Lohinai Z
Mol Oncol; 2020 Sep; 14(9):1947-1965. PubMed ID: 32506804
[TBL] [Abstract][Full Text] [Related]
8. Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer.
Sanchez K; Kim I; Chun B; Pucilowska J; Redmond WL; Urba WJ; Martel M; Wu Y; Campbell M; Sun Z; Grunkemeier G; Chang SC; Bernard B; Page DB
Breast Cancer Res; 2021 Jan; 23(1):2. PubMed ID: 33413574
[TBL] [Abstract][Full Text] [Related]
9. Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence.
Mori H; Bolen J; Schuetter L; Massion P; Hoyt CC; VandenBerg S; Esserman L; Borowsky AD; Campbell MJ
J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):417-432. PubMed ID: 33590360
[TBL] [Abstract][Full Text] [Related]
10. Multiplex Immunofluorescence Tyramide Signal Amplification for Immune Cell Profiling of Paraffin-Embedded Tumor Tissues.
Hernandez S; Rojas F; Laberiano C; Lazcano R; Wistuba I; Parra ER
Front Mol Biosci; 2021; 8():667067. PubMed ID: 33996912
[TBL] [Abstract][Full Text] [Related]
11. Lifetime Exposure to Cigarette Smoke and Risk of Ovarian Cancer by T-cell Tumor Immune Infiltration.
Hathaway CA; Wang T; Townsend MK; Vinci C; Jake-Schoffman DE; Saeed-Vafa D; Moran Segura C; Nguyen JV; Conejo-Garcia JR; Fridley BL; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):66-73. PubMed ID: 36318652
[TBL] [Abstract][Full Text] [Related]
12. Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment.
Gorris MAJ; Halilovic A; Rabold K; van Duffelen A; Wickramasinghe IN; Verweij D; Wortel IMN; Textor JC; de Vries IJM; Figdor CG
J Immunol; 2018 Jan; 200(1):347-354. PubMed ID: 29141863
[TBL] [Abstract][Full Text] [Related]
13. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
[TBL] [Abstract][Full Text] [Related]
14. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.
Yang M; Lu J; Zhang G; Wang Y; He M; Xu Q; Xu C; Liu H
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452206
[TBL] [Abstract][Full Text] [Related]
15. Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.
Jia K; Chen Y; Sun Y; Hu Y; Jiao L; Ma J; Yuan J; Qi C; Li Y; Gong J; Gao J; Zhang X; Li J; Zhang C; Shen L
BMC Med; 2022 Jul; 20(1):223. PubMed ID: 35811317
[TBL] [Abstract][Full Text] [Related]
16. Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues.
Parra ER; Zhai J; Tamegnon A; Zhou N; Pandurengan RK; Barreto C; Jiang M; Rice DC; Creasy C; Vaporciyan AA; Hofstetter WL; Tsao AS; Wistuba II; Sepesi B; Haymaker C
Sci Rep; 2021 Feb; 11(1):4530. PubMed ID: 33633208
[TBL] [Abstract][Full Text] [Related]
17. The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients.
López-Janeiro Á; Villalba-Esparza M; Brizzi ME; Jiménez-Sánchez D; Ruz-Caracuel I; Kadioglu E; Masetto I; Goubert V; Garcia-Ros D; Melero I; Peláez-García A; Hardisson D; de Andrea CE
J Pathol; 2022 Dec; 258(4):426-436. PubMed ID: 36169332
[TBL] [Abstract][Full Text] [Related]
18. CD8 + T cell infiltration is associated with improved survival and negatively correlates with hypoxia in clear cell ovarian cancer.
Guo N; Yang A; Farooq FB; Kalaria S; Moss E; DeVorkin L; Lesperance M; Bénard F; Wilson D; Tinker AV; Nathoo FS; Hamilton PT; Lum JJ
Sci Rep; 2023 Apr; 13(1):6530. PubMed ID: 37085560
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers.
Alwosaibai K; Aalmri S; Mashhour M; Ghandorah S; Alshangiti A; Azam F; Selwi W; Gharaibeh L; Alatawi Y; Alruwaii Z; Alsaab HO
BMC Cancer; 2023 Jan; 23(1):13. PubMed ID: 36604635
[TBL] [Abstract][Full Text] [Related]
20. Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer.
Permuth-Wey J; Boulware D; Valkov N; Livingston S; Nicosia S; Lee JH; Sutphen R; Schildkraut J; Narod S; Parker A; Coppola D; Sellers T; Pal T
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):28-34. PubMed ID: 19124477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
